HS Icon Vaccines, blood, antisera, toxins and cultures in  Flag Japan

2020
Exports | Imports
: $3.08B | $7.9B, World Rnk 14 / 193
Flag Rnk 47 / 1207 | World Rnk 8 / 221
Flag Rnk 12 / 1206

2019 - 2020
FASTEST GROWING MARKET | FASTEST GROWING ORIGIN
: $981M | $916M, United States |  United States

2020
ECONOMIC COMPLEXITY of Japan
: 2.19, Rnk 1 / 127

2020
PRODUCT COMPLEXITY  IN Vaccines, blood, antisera, toxins and cultures
: 1.23, Rnk 112 / 1029

Exports In 2020, Japan exported $3.08B in Vaccines, blood, antisera, toxins and cultures, making it the 14th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 47th most exported product in Japan. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Japan are: Switzerland ($1.12B), United States ($1.04B), Germany ($189M), United Kingdom ($115M), and China ($114M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Japan between 2019 and 2020 were United States ($981M), Switzerland ($711M), and South Korea ($35.1M).

Imports In 2020, Japan imported $7.9B in Vaccines, blood, antisera, toxins and cultures, becoming the 8th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 12th most imported product in Japan. Japan imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($2.22B), Ireland ($1.73B), Switzerland ($1.55B), Germany ($1.09B), and Belgium ($241M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Japan between 2019 and 2020 were United States ($916M), Switzerland ($162M), and South Korea ($83.6M).

December 2021

Subnational Monthly Trade

#permalink to section
Time Scale
Flow
Value

EXPORT GROWTH (December 2020 - December 2021): ¥12.1B, (90.4%)

IMPORT GROWTH (December 2020 - December 2021): ¥20.3B, (21.9%)

MAIN EXPORTER (December 2021): ,

MAIN DESTINATION (December 2021): ,

This section shows Vaccines, blood, antisera, toxins and cultures's exports and imports data at subnational level for Japan. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Vaccines, blood, antisera, toxins and cultures over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download

Historical Data

#permalink to section
Value
Compare to

EXPORTS (2020): $3.08B

IMPORTS (2020): $7.9B

NET TRADE (2020): -$4.82B

In 2020, Japan exported $3.08B in Vaccines, blood, antisera, toxins and cultures. The main destinations of Japan exports on Vaccines, blood, antisera, toxins and cultures were Switzerland ($1.12B), United States ($1.04B), Germany ($189M), United Kingdom ($115M), and China ($114M).

In 2020, Japan imported $7.9B in Vaccines, blood, antisera, toxins and cultures, mainly from United States ($2.22B), Ireland ($1.73B), Switzerland ($1.55B), Germany ($1.09B), and Belgium ($241M).

Explore Visualizations

Flow

THE FASTEST GROWING Vaccines, blood, antisera, toxins and cultures EXPORT MARKETS FOR Japan WERE (2019 - 2020):

THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Vaccines, blood, antisera, toxins and cultures BY Japan WERE (2019 - 2020):

Explore Visualizations

Market Concentration

#permalink to section
View
Flow
Type

In 2020, Japan's main exporting competitors in Vaccines, blood, antisera, toxins and cultures were:

In 2020, Japan's main importing competitors in Vaccines, blood, antisera, toxins and cultures were:

Explore Visualizations